/NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES/
TORONTO, Dec. 4, 2017 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF) ("Liberty" or the "Company") announced that on December 4, 2017 the Board of Directors of the Company granted 7,445,000 options to purchase common stock to various directors and officers, at an exercise price of $1.62, for a term of 5 years, pursuant to the Company's incentive stock option plan.
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. ("Liberty") is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
For more information about Liberty please visit www.libertyhealthsciences.com
SOURCE Liberty Health Sciences Inc.
For further information: For media inquiries, please contact: Matt Salvatore, Edelman, [email protected], 613.315.7362